European Archives - Page 672 of 1060 - European Medical Journal

Type 2 Diabetes Mellitus Reversed through White Adipose Tissue Targeting

A team of researchers from University of British Columbia, Vancouver, Canada, and the Karolinska Institute, Solna, Sweden, have produced findings showing…

Liver Fat Reduction and Blood Sugar Level Improvements Shown Through Strength Training

Although it is widely accepted that regular exercise and a healthy diet can prevent the onset of type 2 diabetes mellitus, the precise molecular mechanisms…

Novel Alopecia Treatment Shows Promise in Clinical Trial

Affecting approximately 50 million men and 30 million women in the USA, androgenetic alopecia (AGA) is the most common form of hair loss…

Topical Cream Shows Initial Success for Vitiligo Repigmentation

With no Food and Drug Administration (FDA)-approved treatments available for repigmenting in vitiligo, limited improvements in vitiligo patients can be…

Implementing Blue Light Flexible Cystoscopy in Non-Muscle Invasive Bladder Cancer Surveillance

Surveillance protocols for non-muscle-invasive bladder cancer (NMIBC) involve regular cystoscopy evaluations to detect recurrent disease, which occurs in..

EMJ Urology 7 [Suppl 1] 2019

White light cystoscopy (WLC) has long been the standard procedure for visualisation of non-muscle-invasive bladder cancer (NMIBC), both during…

The European Medical Journal Presents: EMJ Interventional Cardiology 2019

EMJ Interventional Cardiology 7.1 contains a host of content from this year’s EuroPCR congress: a congress rife with technological advancements in the…

EMJ Interventional Cardiology 7.1 2019

The sharing of knowledge and best-practice is pivotal in a field with such high stakes, and EuroPCR plays a key role in the international collaboration…

Review of the EuroPCR Congress 2019

Paris: The city of love, oozing with art and culture, is celebrated for its wine, cheese, wide boulevards, and idyllic strolls along the river Seine…

EuroPCR 2019 Feature: To Clip or Not to Clip

Despite advances, open-heart surgery remains a risky procedure, and its risk–benefit profile means that it is not an option for all patients with severe…